Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.20.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The table below shows certain financial information of our reporting segments as of and for the years ended December 31, 2019 and 2018 (in thousands).

 

Segment Reporting as of and for the year ended December 31, 2019

 

    Treatment     Services     Medical     Segments Total     Corporate (2)     Consolidated Total  
Revenue from external customers   $ 40,364     $ 33,095           $ 73,459 (3)(4)   $     $ 73,459  
Intercompany revenues     329       38             367              
Gross profit     12,248       3,336             15,584             15,584  
Research and development     401       12       314       727       23       750  
Interest income                             337       337  
Interest expense     (129 )     (23 )           (152 )     (280 )     (432 )
Interest expense-financing fees                             (208 )     (208 )
Depreciation and amortization     999       318             1,317       25       1,342  
Segment income (loss) before income taxes     7,973       795       (314 )     8,454       (5,565 )     2,889  
Income tax expense     153                   153       4       157  
Segment income (loss)     7,820       795       (314 )     8,301       (5,569 )     2,732  
Segment assets(1)     34,260       15,410 (10)     16       49,686       16,829 (5)     66,515  
Expenditures for segment assets (net)     169       1,366             1,535             1,535 (9)
Total debt                             3,880       3,880 (6)

 

Segment Reporting as of and for the year ended December 31, 2018

 

    Treatment     Services     Medical     Segments Total     Corporate (2)     Consolidated Total  
Revenue from external customers   $ 36,271     $ 13,268           $ 49,539 (3)(4)   $     $ 49,539  
Intercompany revenues     509       70             579              
Gross profit     7,197       1,264             8,461             8,461  
Research and development     483             811       1,294       76       1,370  
Interest income                             295       295  
Interest expense     (22 )     (2 )           (24 )     (227 )     (251 )
Interest expense-financing fees                             (38 )     (38 )
Depreciation and amortization     943       465             1,408       47       1,455  
Segment income (loss) before income taxes     4,550 (7)     (756 )     (811 )     2,983       (4,993 )     (2,010 )
Income tax (benefit) expense     (943 )(8)                 (943 )     7       (936 )
Segment income (loss)     5,493       (756 )     (811 )     3,926       (5,000 )     (1,074 )
Segment assets(1)     32,800       5,188 (10)     25       38,013       19,429 (5)     57,442  
Expenditures for segment assets (net)     1,311       117             1,428       4       1,432 (9)
Total debt                             3,302       3,302 (6)

 

(1) Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment.
   
(2) Amounts reflect the activity for corporate headquarters not included in the segment information.
   
(3) The Company performed services relating to waste generated by government clients (domestic and foreign (primarily Canadian)), either directly as a prime contractor or indirectly for others as a subcontractor to government entities, representing approximately $59,985,000 or 81.7% of total revenue for 2019 and $35,944,000 or 72.6% of total revenue for 2018. The following reflects such revenue generated by our two segments:

 

    2019     2018  
    Treatment     Services     Total     Treatment     Services     Total  
Domestic government   $ 29,420     $ 25,077     $ 54,497     $ 25,181     $ 9,630     $ 34,811  
Foreign government     279       5,209       5,488       114       1,019       1,133  
Total   $ 29,699     $ 30,286     $ 59,985     $ 25,295     $ 10,649     $ 35,944  

 

(4) The following table reflects revenue based on customer location:

 

    2019     2018  
United States   $ 67,822     $ 48,301  
Canada     5,488       1,140  
United Kingdom     149       98  
Total   $ 73,459     $ 49,539  

 

(5) Amount includes assets from our discontinued operations of $221,000 and $306,000 at December 31, 2019 and 2018, respectively.
   
(6) Net of debt discount/debt issuance costs of ($340,000) and ($80,000) for 2019 and 2018, respectively (see “Note 10 – “Long-Term Debt” for additional information).
   
(7) Amount includes a net gain of $1,596,000 recorded resulting from the exchange offer of the Series B Preferred Stock of the Company’s M&EC subsidiary (see “Note 8 – Series B Preferred Stock”)
   
(8) For the year ended December 31, 2018, amount includes a tax benefit recorded in the amount of approximately $1,235,000 resulting from certain provisions of the TCJA (see “Note 13 – Income Taxes” for further information of this tax benefit).
   
(9) Net of financed amount of $393,000 and $545,000 for the year ended December 31, 2019 and 2018, respectively.
   
(10) Includes long-lived asset (net) for our PF Canada, Inc. subsidiary of $41,000 and $0, for the year ended December 31, 2019 and 2018, respectively.

Schedule of Revenue by Major Customers by Reporting Segments

    2019     2018
    Treatment     Services     Total     Treatment     Services     Total
Domestic government   $ 29,420     $ 25,077     $ 54,497     $ 25,181     $ 9,630     $ 34,811
Foreign government     279       5,209       5,488       114       1,019       1,133
Total   $ 29,699     $ 30,286     $ 59,985     $ 25,295     $ 10,649     $ 35,944

Schedule of Revenue Based on Customer Location

 

    2019     2018  
United States   $ 67,822     $ 48,301  
Canada     5,488       1,140  
United Kingdom     149       98  
Total   $ 73,459     $ 49,539